Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair

I. Kalasova, R. Hailstone, J. Bublitz, J. Bogantes, W. Hofmann, A. Leal, H. Hanzlikova, KW. Caldecott,

. 2020 ; 48 (12) : 6672-6684. [pub] 20200709

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc20024890

Grant support
MR/P010121/1 Medical Research Council - United Kingdom

Hereditary mutations in polynucleotide kinase-phosphatase (PNKP) result in a spectrum of neurological pathologies ranging from neurodevelopmental dysfunction in microcephaly with early onset seizures (MCSZ) to neurodegeneration in ataxia oculomotor apraxia-4 (AOA4) and Charcot-Marie-Tooth disease (CMT2B2). Consistent with this, PNKP is implicated in the repair of both DNA single-strand breaks (SSBs) and DNA double-strand breaks (DSBs); lesions that can trigger neurodegeneration and neurodevelopmental dysfunction, respectively. Surprisingly, however, we did not detect a significant defect in DSB repair (DSBR) in primary fibroblasts from PNKP patients spanning the spectrum of PNKP-mutated pathologies. In contrast, the rate of SSB repair (SSBR) is markedly reduced. Moreover, we show that the restoration of SSBR in patient fibroblasts collectively requires both the DNA kinase and DNA phosphatase activities of PNKP, and the fork-head associated (FHA) domain that interacts with the SSBR protein, XRCC1. Notably, however, the two enzymatic activities of PNKP appear to affect different aspects of disease pathology, with reduced DNA phosphatase activity correlating with neurodevelopmental dysfunction and reduced DNA kinase activity correlating with neurodegeneration. In summary, these data implicate reduced rates of SSBR, not DSBR, as the source of both neurodevelopmental and neurodegenerative pathology in PNKP-mutated disease, and the extent and nature of this reduction as the primary determinant of disease severity.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20024890
003      
CZ-PrNML
005      
20201222153610.0
007      
ta
008      
201125s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/nar/gkaa489 $2 doi
035    __
$a (PubMed)32504494
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kalasova, Ilona $u Department of Genome Dynamics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, 142 20, Czech Republic.
245    10
$a Pathological mutations in PNKP trigger defects in DNA single-strand break repair but not DNA double-strand break repair / $c I. Kalasova, R. Hailstone, J. Bublitz, J. Bogantes, W. Hofmann, A. Leal, H. Hanzlikova, KW. Caldecott,
520    9_
$a Hereditary mutations in polynucleotide kinase-phosphatase (PNKP) result in a spectrum of neurological pathologies ranging from neurodevelopmental dysfunction in microcephaly with early onset seizures (MCSZ) to neurodegeneration in ataxia oculomotor apraxia-4 (AOA4) and Charcot-Marie-Tooth disease (CMT2B2). Consistent with this, PNKP is implicated in the repair of both DNA single-strand breaks (SSBs) and DNA double-strand breaks (DSBs); lesions that can trigger neurodegeneration and neurodevelopmental dysfunction, respectively. Surprisingly, however, we did not detect a significant defect in DSB repair (DSBR) in primary fibroblasts from PNKP patients spanning the spectrum of PNKP-mutated pathologies. In contrast, the rate of SSB repair (SSBR) is markedly reduced. Moreover, we show that the restoration of SSBR in patient fibroblasts collectively requires both the DNA kinase and DNA phosphatase activities of PNKP, and the fork-head associated (FHA) domain that interacts with the SSBR protein, XRCC1. Notably, however, the two enzymatic activities of PNKP appear to affect different aspects of disease pathology, with reduced DNA phosphatase activity correlating with neurodevelopmental dysfunction and reduced DNA kinase activity correlating with neurodegeneration. In summary, these data implicate reduced rates of SSBR, not DSBR, as the source of both neurodevelopmental and neurodegenerative pathology in PNKP-mutated disease, and the extent and nature of this reduction as the primary determinant of disease severity.
650    _2
$a apraxie $x genetika $x patologie $7 D001072
650    _2
$a Charcotova-Marieova-Toothova nemoc $x genetika $x patologie $7 D002607
650    12
$a dvouřetězcové zlomy DNA $7 D053903
650    12
$a jednořetězcové zlomy DNA $7 D053904
650    _2
$a oprava DNA $x genetika $7 D004260
650    _2
$a enzymy opravy DNA $x genetika $7 D045643
650    _2
$a fibroblasty $x metabolismus $x patologie $7 D005347
650    _2
$a lidé $7 D006801
650    _2
$a mikrocefalie $x genetika $x patologie $7 D008831
650    _2
$a mutace $x genetika $7 D009154
650    _2
$a fosfotransferasy s alkoholovou skupinou jako akceptorem $x genetika $7 D017853
650    _2
$a záchvaty $x genetika $x patologie $7 D012640
650    _2
$a protein XRCC1 $x genetika $7 D000076105
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hailstone, Richard $u Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RQ, UK.
700    1_
$a Bublitz, Janin $u Department of Human Genetics, Hannover Medical School, Hannover, Germany.
700    1_
$a Bogantes, Jovel $u Servicio de Cirugía Reconstructiva, Hospital Rafael Ángel Calderón Guardia, Caja Costarricense de Seguro Social, San José, Costa Rica.
700    1_
$a Hofmann, Winfried $u Department of Human Genetics, Hannover Medical School, Hannover, Germany.
700    1_
$a Leal, Alejandro $u Section of Genetics and Biotechnology, School of Biology, University of Costa Rica, San José, Costa Rica.
700    1_
$a Hanzlikova, Hana $u Department of Genome Dynamics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, 142 20, Czech Republic. Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RQ, UK.
700    1_
$a Caldecott, Keith W $u Department of Genome Dynamics, Institute of Molecular Genetics of the Czech Academy of Sciences, Prague 4, 142 20, Czech Republic. Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton BN1 9RQ, UK.
773    0_
$w MED00003554 $t Nucleic acids research $x 1362-4962 $g Roč. 48, č. 12 (2020), s. 6672-6684
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32504494 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222153606 $b ABA008
999    __
$a ok $b bmc $g 1599035 $s 1115576
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 48 $c 12 $d 6672-6684 $e 20200709 $i 1362-4962 $m Nucleic acids research $n Nucleic Acids Res $x MED00003554
GRA    __
$a MR/P010121/1 $p Medical Research Council $2 United Kingdom
LZP    __
$a Pubmed-20201125

Find record

Citation metrics

Archiving options